Biograph Vision
Product type: Digital PET/CT
Vendor: Siemens Healthineers
Installed at: Apollo Proton Cancer Centre, Chennai
With nearly a million new cancer cases diagnosed per annum in India, staging disease more accurately and defining treatment strategies better is the need of the hour. The introduction of Biograph Vision in India that addresses cancer progression with personalised medicine will help deliver the right treatment to the right patient and at the right time.
PET/CT is indispensable as a diagnostic and prognostic tool in the assessment of patient response to cancer therapy and cancer recurrence. Biograph Vision enables a better understanding of disease progression and treatment resistance, to define treatments that can be precisely tailored for patients. Biograph Vision was introduced at Apollo Proton Cancer Centre in Chennai.
“Biograph Vision is designed for improved accuracy, performance, and reproducibility to deliver a whole new world of precision in PET/CT imaging. With the market’s fastest timeoff light and highest effective sensitivity, Biograph Vision helps reduce scan time and injected dose, reducing patient exposure to radiation. The introduction of Biograph Vision at Apollo Proton Cancer Centre will enhance the quality of patient care and expand precision medicine,” said Vivek Kanade, executive director, Siemens Healthineers, India.
هذه القصة مأخوذة من طبعة September 2019 من Healthcare Radius.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة September 2019 من Healthcare Radius.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
KIMSHEALTH launches electrophysiology lab with 3D mapping
'ENSITE X' is the first of its kind in Kerala and the third in India enabling precise identification, mapping, and targeting the abnormal electrical activities in the heart.
Molbio boosts Goa's healthcare system with CSR initiatives
The company has donated four state-of-the-art Advanced Life Support (ALS) ambulances and two hearse vans for National Highway emergencies
USV introduces affordable heart failure medication
This cost-effective option addresses the rising cases of heart failure in India, offering lifesaving care to millions of patients who need it the most.
City Imaging & Clinical Labs to expand services to 50 hospitals
The company is currently associated with 10 hospitals, providing comprehensive lab management services, including 24/7 in-house phlebotomy and lab testing.
Oncare raises $1 million in seed funding, to set up 10 units
Oncare has raised $1 million in a seed funding round led by Huddle Ventures. It plans to deploy the raised capital to expand its operations to 10 new centers.
Nutrabay forays into Ayurvedic supplements market with Shilajit
Nutrabay's aims at gaining market share from the existing ayurveda supplements market with a distinctive product proposition and education about the benefits of Shilajit.
INDIA'S PREPAREDNESS ON HEALTHCARE-ASSOCIATED INFECTIONS: A GROWING FOCUS ON PATIENT SAFETY
The country's diverse healthcare landscape necessitates a flexible and multifaceted approach to infection control that can be adapted to various settings and resource levels.
TRANSFORMING CARDIAC SURGERY: HOW AI IS REVOLUTIONIZING PATIENT CARE AND OUTCOMES
Dr. Swarup Swaraj Pal shared his insights on the current state and future prospects of AI in cardiac procedures.
BEYOND THE LAB: THE CRITICAL ROLE OF LOGISTICS IN INDIA'S PHARMACEUTICAL INDUSTRY
As India continues to expand its role in the global pharmaceutical market, the importance of a robust, reliable, and innovative logistics infrastructure cannot be overstated.
LIFESTYLE DISEASES IN CHILDREN: A WAKE-UP CALL FOR A HEALTHIER GENERATION
In today's fast-paced world, children face an unexpected enemy: lifestyle diseases. Conditions like obesity, Type 2 diabetes, and hypertension are now affecting our youth. What's causing this shift, and how can we combat it?